Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Ipca Laboratories has been moving up. We didn't track it till yesterday. It is making new highs, new highs are bullish and yesterday it did retreat after making those new highs. I would be a buyer here. It is not a day trade; essentially we are looking at an entry today and then waiting for the next few days to get some gains."
At 10:37 hrs Ipca Laboratories was quoting at Rs 681.45, up Rs 10, or 1.49 percent. It has touched an intraday high of Rs 685.55 and an intraday low of Rs 674.85.
The company's trailing 12-month (TTM) EPS was at Rs 20.31 per share. (Mar, 2013). The stock's price-to-earnings (P/E) ratio was 33.55. The latest book value of the company is Rs 126.28 per share. At current value, the price-to-book value of the company was 5.4. The dividend yield of the company was 0.47 percent.
Also Read: Indore facility to start production in 2 months: Ipca Labs
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
